Correction and Clarification: Trifecta and Edward Fruitman, M.D., Do Not Maintain Any Contractual Relationship or Product Preference With Eli Lilly or LillyDirect®

The organization reiterates it has no partnership with Lilly and does not endorse or favor Eli Lilly products, including Zepbound®, in its weight-loss and medical services.

    NEW YORK, NY, November 20, 2025 -- Trifecta Med Spa, Trifecta Health, and Edward Fruitman, M.D. (collectively, "Trifecta") issue the following correction and clarification regarding recent statements circulating online.

Trifecta does not have any contractual relationship, partnership, agreement, affiliation, or cooperation arrangement of any kind with Eli Lilly, LillyDirect®, or any Eli Lilly subsidiary. Likewise, Eli Lilly and LillyDirect® have not entered into any contractual relationship or partnership with Trifecta.

Trifecta does not endorse, promote, or show preference for any Eli Lilly products, including Zepbound®, in the course of its medical or weight-loss services.

Trifecta will continue to cooperate with any licensed pharmacy or pharmacy service provider that can offer the best quality of care, value, and pricing for its patients. Trifecta has not entered — nor does it plan to enter — into any exclusive pharmacy arrangement, product preference policy, or partnership with Eli Lilly or LillyDirect®.

Trifecta Health and Trifecta Med Spa remain committed to providing evidence-based, patient-centered weight-loss and wellness services, free of any manufacturer or pharmacy influence.

For more information, visit https://trifectamedspanyc.com/weight-management-program

# # #

Contact Information
Edward Fruitman
Trifecta

New York, NY
USA
Voice: 9177963348
Website: Visit Our Website

Disclaimer
If you have any questions regarding information in this press release, please contact the person listed in the contact module of this page. Please do not attempt to contact Dragstrip Communications Newswire. We are unable to assist you with any information regarding this release. Dragstrip Communications Newswire disclaims any content contained in this press release. Please see our complete Terms of Service disclaimer for more information.